Womens increased body fat and monthly hormone changes may affect their metabolization of certain drugs
Multiple endocrine neoplasia syndrome type 2 (MEN2): Patients with MEN2 should not receive cagrilintide because of its receptor overlap with calcitonin pathways
Only 5% of studies use real patient care data, while critical factors like fairness, deployment readiness, and calibration remain largely unexamined
The FDA requires specific warnings in prescribing information based on animal study findings and theoretical concerns
Insulin resistance and appetite regulation in PCOS If you have PCOS, youve probably heard the term insulin resistance more times than you can count
But new research exploring what happens when you stop taking them paints a grim picture of how quickly these benefits can rebound, raising urgent questions as many patients end up quitting the drugs due to their costs, availability, and side effects